https://nl.marketscreener.com/koers/aandeel/TCR2-THERAPEUTICS-INC-54658402/nieuws/Adaptimmune-Therapeutics-plc-NasdaqGS-ADAP-heeft-de-overname-afgerond-van-TCR2-Therapeutics-Inc--44032238/?utm_source=telegram&utm_medium=social&utm_campaign=share